scholarly journals The rationale and design of Insight into Nephrotic Syndrome: Investigating Genes, Health and Therapeutics (INSIGHT): a prospective cohort study of childhood nephrotic syndrome

2013 ◽  
Vol 14 (1) ◽  
Author(s):  
Neesha Hussain ◽  
J Anastasia Zello ◽  
Jovanka Vasilevska-Ristovska ◽  
Tonny M Banh ◽  
Viral P Patel ◽  
...  
2019 ◽  
Vol 34 (9) ◽  
pp. 1599-1605 ◽  
Author(s):  
Natalia Konstantelos ◽  
Tonny Banh ◽  
Viral Patel ◽  
Jovanka Vasilevska-Ristovska ◽  
Karlota Borges ◽  
...  

2021 ◽  
Author(s):  
Vanessa Natalie Frey ◽  
Patrick Langthaler ◽  
Emanuel Raphaelis ◽  
Susanne Ring-Dimitriou ◽  
Ludmilla Kedenko ◽  
...  

Abstract Paracelsus 10,000 is a prospective cohort study with the objective to investigate the health status of the population in and around the city of Salzburg. The focus lies on common non-communicable diseases, mainly cardiovascular and cerebrovascular diseases, and their risk factors in a population-based cohort aged between 40 and 70 years. Between the years 2013 and 2020, 10,062 randomly selected participants (w: 5,187, m: 4,875) were investigated, of whom 2,620 underwent an intensified examination. The program consists not only of medical examinations, but was extended to inventories on mental disorders, lifestyle including nutrition and physical activity. From all study participants biological samples were stored in a biobank at -80°C enabling future investigations of biomarkers and utilization of the whole spectrum of multi-omics. The first follow-up phase of the study has started in late 2020 and will allow us to investigate the development of common non-communicable diseases occurring over time in the cohort of the Paracelsus 10,000 study. This gives the study a unique position within the framework of Austrian epidemiological research with the potential to gain new insight into the role of interaction between genetic predisposition and lifestyle factors for disease development in the Salzburg population. Obtaining high-quality epidemiological data is also of particular relevance for the development of evidence-based prevention strategies. This report describes rationale, objectives and design of the study and provides insight into the main characteristics of the study cohort.


Author(s):  
Jing Xu ◽  
Ying Ding ◽  
Li Wan ◽  
Qinghua Yang ◽  
Zhen Qu

Abstract Objective To explore the efficacy and safety of rituximab (RTX) in the treatment of autoimmune nephropathy manifested as refractory nephrotic syndrome (RNS). Methods A single-center prospective cohort study was conducted on RNS patients treated with RTX between March 2017 and December 2019. The subjects were divided into the primary nephropathy (PN) group and the secondary nephropathy (SN) group. Based on the estimated glomerular filtration rate (eGFR) before RTX treatment, the SN group was then divided into the SN-1 group (eGFR ≥ 30 ml/min) and the SN-2 group (eGFR < 30 ml/min). Biochemical parameters and clinical data were recorded during follow-up. Results Fifty-four patients were followed up for at least 6 months. The overall remission rates were 65%, 66.7%, 27.3% in the PN, SN-1, and SN-2 groups, respectively (P = 0.022). Kaplan–Meier analysis showed a significant difference of the renal survival among the three subgroups (P < 0.001). Multivariate Cox regression analysis showed that eGFR value before treatment was an independent predictor (HR 0.919, 95%CI 0.863–0.979) for renal survival. In terms of adverse events, infection accounted for 56.6%. The incidence of severe infection was 10%, 25% and 50% in PN group, SN-1 group and SN-2 group, respectively. Conclusions RTX may be a promising option in RNS patients with eGFR ≥ 30 ml/min/1.73m2. However, it has little effect on prognosis in patients with secondary RNS with eGFR < 30 ml/min/1.73m2, but with a high risk of severe infection.


BMC Cancer ◽  
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
T. M. Ripping ◽  
◽  
L. A. Kiemeney ◽  
L. M. C. van Hoogstraten ◽  
J. A. Witjes ◽  
...  

2014 ◽  
Vol 29 (6) ◽  
pp. 1039-1046 ◽  
Author(s):  
Premala Sureshkumar ◽  
Elisabeth M. Hodson ◽  
Narelle S. Willis ◽  
Federica Barzi ◽  
Jonathan C. Craig

Sign in / Sign up

Export Citation Format

Share Document